Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTX Nkarta

未开盘 12-19 16:00:00 EST

2.20

+0.03

+1.38%

盘后2.19

-0.01-0.45%

19:48 EST

最高2.23	最低2.08	成交量257.25万
今开2.18	昨收2.17	日振幅6.91%
总市值1.55亿	流通市值9,655万	总股本7,057万
成交额551.77万	换手率5.86%	流通股本4,389万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":2.2,"timestamp":1734642000000,"preClose":2.17,"halted":0,"volume":2572482,"hourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.2,"latestTime":"19:48 EST","volume":8737,"amount":19187.05,"timestamp":1734655693407},"delay":0,"floatShares":43886072,"shares":70568754,"eps":-1.791781,"marketStatus":"未开盘","marketStatusCode":0,"change":0.03,"latestTime":"12-19 16:00:00 EST","open":2.18,"high":2.23,"low":2.08,"amount":5517695.2901994,"amplitude":0.069124,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.791781,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734685200000},"adr":0,"listingDate":1594353600000,"adjPreClose":2.17,"preHourTrading":{"tag":"盘前","latestPrice":2.2,"preClose":2.17,"latestTime":"09:27 EST","volume":1659,"amount":3675.4292274000004,"timestamp":1734618455864},"postHourTrading":{"tag":"盘后","latestPrice":2.19,"preClose":2.2,"latestTime":"19:48 EST","volume":8737,"amount":19187.05,"timestamp":1734655693407},"volumeRatio":1.164787,"impliedVol":1.5897,"impliedVolPercentile":0.8016},"requestUrl":"/m/hq/s/NKTX","defaultTab":"news","newsList":[{"id":"2492800791","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492800791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492800791?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:43","pubTimestamp":1734533024,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时43分，Nkarta, Inc.股票出现异动，股价大幅上涨5.29%。截至发稿，该股报2.39美元/股，成交量16.0821万股，换手率0.23%，振幅5.29%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224344984cb2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224344984cb2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2491309127","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491309127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491309127?lang=zh_cn&edition=full","pubTime":"2024-12-14 02:14","pubTimestamp":1734113688,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日02时14分，Nkarta, Inc.股票出现波动，股价快速上涨5.46%。截至发稿，该股报2.42美元/股，成交量163.532万股，换手率2.32%，振幅6.99%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214021448ab75eea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214021448ab75eea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2491336527","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491336527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491336527?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:23","pubTimestamp":1734020624,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时23分，Nkarta, Inc.股票出现波动，股价快速下跌5.56%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3472.19%、884.12%、77.53%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为115.92%、86.92%、80.04%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002344984b9b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002344984b9b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2490417690","title":"Nkarta, Inc.盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490417690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490417690?lang=zh_cn&edition=full","pubTime":"2024-12-11 01:52","pubTimestamp":1733853131,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时52分，Nkarta, Inc.股票出现异动，股价急速上涨5.26%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1971.90%、470.20%、170.13%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.，振幅分别为154.91%、131.78%、121.49%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121101521195e8b7f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121101521195e8b7f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2489468143","title":"Nkarta, Inc.盘中异动 早盘大幅跳水5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468143?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:45","pubTimestamp":1733409934,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时45分，Nkarta, Inc.股票出现波动，股价快速下挫5.51%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Silexion Therapeutics Corp、Molecular Templates, Inc.较为活跃，换手率分别为2049.54%、209.61%、75.40%，振幅较大的相关个股有Psyence Biomedical Ltd.、Aprea Therapeutics, Inc.、Molecular Templates, Inc.，振幅分别为29.76%、20.90%、19.51%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205224534971be226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205224534971be226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2489149081","title":"Nkarta, Inc.盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489149081","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489149081?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:03","pubTimestamp":1733331787,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时03分，Nkarta, Inc.股票出现异动，股价快速拉升5.19%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为3332.60%、256.88%、131.16%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.，振幅分别为237.89%、61.31%、55.22%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205010307971ba778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205010307971ba778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2488794656","title":"Nkarta, Inc.盘中异动 急速跳水5.61%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488794656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488794656?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:46","pubTimestamp":1733237175,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时46分，Nkarta, Inc.股票出现波动，股价大幅跳水5.61%。截至发稿，该股报2.86美元/股，成交量10.1485万股，换手率0.14%，振幅9.09%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224615a2699da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224615a2699da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2488047646","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488047646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488047646?lang=zh_cn&edition=full","pubTime":"2024-12-03 02:11","pubTimestamp":1733163100,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日02时11分，Nkarta, Inc.股票出现波动，股价大幅拉升5.05%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2533.89%、2393.89%、641.39%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203021140abf068d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203021140abf068d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2487856659","title":"Nkarta, Inc.盘中异动 早盘急速下挫5.52%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487856659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487856659?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:37","pubTimestamp":1732894670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时37分，Nkarta, Inc.股票出现波动，股价急速跳水5.52%。截至发稿，该股报2.83美元/股，成交量73.1365万股，换手率1.04%，振幅4.68%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923375098e46922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923375098e46922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2486878228","title":"Nkarta, Inc.盘中异动 早盘急速拉升6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486878228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486878228?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:33","pubTimestamp":1732717984,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时33分，Nkarta, Inc.股票出现异动，股价大幅拉升6.13%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为797.31%、27.20%、6.90%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.，振幅分别为19.11%、13.97%、11.32%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722330498e44ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722330498e44ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2486103856","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.31%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486103856?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545131,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Nkarta, Inc.股票出现异动，股价快速上涨5.31%。截至发稿，该股报2.58美元/股，成交量3.0716万股，换手率0.04%，振幅1.63%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223211a2548c6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223211a2548c6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2483382722","title":"Nkarta, Inc.盘中异动 股价大跌5.33%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483382722?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:29","pubTimestamp":1731605397,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时29分，Nkarta, Inc.股票出现异动，股价快速跳水5.33%。截至发稿，该股报2.76美元/股，成交量46.7047万股，换手率0.66%，振幅5.15%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012958971a69d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012958971a69d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2483583302","title":"Nkarta, Inc.2024财年第三财季实现净利润-28.34百万美元，同比减少10.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483583302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483583302?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:00","pubTimestamp":1731513633,"startTime":"0","endTime":"0","summary":"11月14日，Nkarta, Inc.公布财报，公告显示公司2024财年第三财季净利润为-28.34百万美元，同比减少10.49%；其中营业收入为0.00美元，每股基本收益为-0.39美元。从资产负债表来看，Nkarta, Inc.总负债1.01亿美元，其中短期债务6.76百万美元，资产负债比为5.27，流动比率为0.13。机构评级：截至2024年11月14日，当前有7家机构对Nkarta, Inc.目标价做出预测，其中目标均价为16.86美元，其中最低目标价为11.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000115a2348677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000115a2348677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX"],"gpt_icon":0},{"id":"2482738415","title":"Nkarta, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738415?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:38","pubTimestamp":1731335934,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时38分，Nkarta, Inc.股票出现异动，股价快速上涨5.02%。截至发稿，该股报3.35美元/股，成交量3.543万股，换手率0.05%，振幅3.45%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223855971a5b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223855971a5b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2481110174","title":"Nkarta, Inc.盘中异动 早盘快速跳水5.06%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110174?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:33","pubTimestamp":1731076414,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时33分，Nkarta, Inc.股票出现异动，股价快速下跌5.06%。截至发稿，该股报3.10美元/股，成交量3.6701万股，换手率0.05%，振幅4.59%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822333498e4178c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822333498e4178c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2481158588","title":"Nkarta, Inc.盘中异动 下午盘急速下跌5.07%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481158588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481158588?lang=zh_cn&edition=full","pubTime":"2024-11-08 03:21","pubTimestamp":1731007289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日03时21分，Nkarta, Inc.股票出现波动，股价急速跳水5.07%。截至发稿，该股报3.18美元/股，成交量35.098万股，换手率0.50%，振幅5.67%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108032129abaafdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108032129abaafdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2481617727","title":"Nkarta Inc    预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481617727","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481617727?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:26","pubTimestamp":1730870802,"startTime":"0","endTime":"0","summary":"   * Nkarta Inc    预计在11月7日公布截至2024年9月30日的财报时，季度收入将没有变化(预计)    *    * LSEG 的分析师平均预计 Nkarta Inc 每股亏损 36 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 9 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Nkarta Inc 的 12 个月目标价中位数为 17.00 美元，高于其上次收盘价 3.25 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nkarta Inc    预计每股亏损 36 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTX"],"gpt_icon":0},{"id":"2480587640","title":"Nkarta, Inc.盘中异动 早盘快速上涨5.02%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587640?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:19","pubTimestamp":1730733599,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时19分，Nkarta, Inc.股票出现波动，股价快速上涨5.02%。截至发稿，该股报3.35美元/股，成交量12.1845万股，换手率0.17%，振幅5.80%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232000a2155f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232000a2155f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2480088481","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.19%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480088481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480088481?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:01","pubTimestamp":1730469717,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时01分，Nkarta, Inc.股票出现异动，股价快速上涨5.19%。截至发稿，该股报3.24美元/股，成交量6.4678万股，换手率0.09%，振幅4.22%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101220157a2096efe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101220157a2096efe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2479033764","title":"Nkarta, Inc.盘中异动 急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033764?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:58","pubTimestamp":1730383107,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时58分，Nkarta, Inc.股票出现波动，股价急速下跌5.07%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为2.41%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为215.34%、214.82%、153.84%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为45.05%、39.30%、28.17%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215827a2023aca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215827a2023aca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":-0.1129},{"period":"3month","weight":-0.5777},{"period":"6month","weight":-0.6},{"period":"1year","weight":-0.4005},{"period":"ytd","weight":-0.6667}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司，致力于开发工程化的自然杀伤（NK）细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞，并募集适应性免疫效应子以产生特异性和持久性的反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.112423},{"month":2,"riseRate":0.5,"avgChangeRate":0.066988},{"month":3,"riseRate":0.25,"avgChangeRate":-0.082272},{"month":4,"riseRate":0.5,"avgChangeRate":0.150196},{"month":5,"riseRate":0.25,"avgChangeRate":-0.125785},{"month":6,"riseRate":0.25,"avgChangeRate":-0.12509},{"month":7,"riseRate":1,"avgChangeRate":0.058112},{"month":8,"riseRate":0.4,"avgChangeRate":-0.07656},{"month":9,"riseRate":0.2,"avgChangeRate":-0.069244},{"month":10,"riseRate":0.2,"avgChangeRate":-0.076206},{"month":11,"riseRate":0.6,"avgChangeRate":0.015473},{"month":12,"riseRate":0.4,"avgChangeRate":0.357198}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}